CompoAtlas

Afinity Yin (Women's Health)

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Actaea racemosa

Source : Actaea racemosa - racine

Extraction ratio : 5:1

Dry plant equivalent : 165 mg

33 mgNot calculated
Extrait d'isoflavone de soja

Source : Glycine max - Graine

Potency : 8.9 mg ÉAI Genistein

Not specifiedNot calculated
Extrait d'isoflavone de soja

Source : Extrait d'isoflavone de soja

Potency : 8.9 mg ÉAI Genistein

Not specifiedNot calculated
Extrait d'isoflavone de soja

Source : Glycine max - Graine

Potency : 17.4 mg ÉAI Isoflavones

67 mgNot calculated
Extrait d'isoflavone de soja

Source : Extrait d'isoflavone de soja

Potency : 17.4 mg ÉAI Isoflavones

67 mgNot calculated

Non-medicinal ingredients

Hypromellose, Amidon du riz, cellulose, Maltodextrine, Stéarate de magnésium, Dioxyde de titane, Gélatine

PopulationAgeQuantity per servingFrequency
Femmes ménopausées et en postménopauseNot specifiedminimum: 3 Capsule ; maximum: 4 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

May reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats). Used in Herbal Medicine to help relieve muscle and joint pain associated with rheumatic conditions (such as rheumatoid arthritis, osteoarthritis and/or fibrositis), and of pain associated with neuralgia (such as sciatica). Used in Herbal Medicine to help ease nervous tension (calmative). Semen Ziziphi Spinosae is used in Traditional Chinese Medicine to nourish the heart yin and calm the spirit for relief from insomnia, irritability, and night sweats.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Natural RF Life Sciences Inc.
NPN or DIN-HM
80052843
Status
Active licence
Licence date
1 August 2014
Revision date
15 August 2018
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80052843

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Actaea racemosa
    Read the warning, when it applies and the studies cited

    Black Cohosh - Actaea Racemosa

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder or develop symptoms of liver trouble (EMA 2018, 2007; Lynch et al. 2006; Mills et al. 2006; Cohen et al. 2004; NIH 2004).

    Sources cited by Health Canada (6)
    • Cohen SM, O'Connor AM, Hart J, Merel NH, Te HS. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause: the Journal of the North American Menopause Society 2004;11(5):575-577. PubMed Case report
    • EMA 2018: European Medicines Agency. Committee on Herbal Medicinal Products (HMPC). European Union Herbal monograph on Cimicifuga racemosa (L.) Nutt., rhizome. March 2018. [Accessed 2025 January 3]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-cimicifuga-racemosa-l-nutt-rhizome-revision-1_en.pdf
    • EMA 2007: European Medicines Agency. Committee on Herbal Medicinal Products (HMPC) Annex 1. Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (Black cohosh, root). London (UK): European Medicines Agency; May 20027. [Accessed 2025 January 3]. Available from: https://www.ema.europa.eu/en/documents/herbal-report/assessment-case-reports-connected-herbal-medicinal-products-containing-cimicifugae-racemosae-rhizoma-black-cohosh-root_en.pdf
    • Lynch CR, Folkers ME, Hutson WR. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transplantation 2006;12(6):989-992. PubMed Case report
    • Mills E, Duguoa J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation. New York (NY): Taylor and Francis; 2006.
    • NIH 2004: National Institutes of Health. Workshop on the Safety of Black Cohosh in Clinical Studies. Bethesda (MD): National Institutes of Health, Department of Health and Human Services; November 22, 2004. [Accessed 2024 December 3]. Available from: https://files.nccih.nih.gov/s3fs-public/news/blackcohosh_mtngsumm.pdf

    Contraindications

    Do not use if you are pregnant (Brinker 2010; Hoffmann 2003; Tilgner 1999).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
    • Tilgner S. Herbal Medicine from the Heart of the Earth Creswell (OR): Wise Acre Press; 1999.

    Health Canada monograph dated 31 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Afinity Yin (Women's Health)”, https://compoatlas.com/en/supplements/canada/80052843-afinity-yin-women-s-health, updated 15 August 2018.

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line